Latest Breaking News On - Borrelia ospa - Page 1 : vimarsana.com

Novel vaccine against Lyme disease reported to be safe and effective

Researchers determine the safety and immunogenicity of a novel candidate vaccine against Lyme borreliosis.

United statesLancet infectious diseasesNorth americaBorrelia ospaOspac terminal

Upgraded Lyme Disease Vaccine Promising in Phase I Results

The vaccine neutralizes Lyme-causing bacteria in the tick before it can get to the human

United statesCeske budejoviceCzech republicJan pernerIngrid heinOndrej hajdusekSusanne eder lingelbachCzech academy of sciencesValneva austriaLancet infectiousCzech academyNorth americaBorrelia ospaMedpage todayInfect dis

Intravacc announces positive preclinical data for its OMV-based Lyme vaccine

Intravacc announces positive preclinical data for its OMV-based Lyme vaccine
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesNoord hollandMirjam hartmanPrnewswire intravaccAmsterdam medical centerMelinda gates foundationDutch national institute for public healthLifespring life sciences communicationBorrelia ospaNorth americaJan groenDutch national institutePublic healthUtrecht science park bilthovenSpring life sciences communicationஒன்றுபட்டது மாநிலங்களில்

Latest Breaking News On - Borrelia ospa - Page 1 : vimarsana.com

Novel vaccine against Lyme disease reported to be safe and effective

Researchers determine the safety and immunogenicity of a novel candidate vaccine against Lyme borreliosis.United statesLancet infectious diseasesNorth americaBorrelia ospaOspac terminal

Upgraded Lyme Disease Vaccine Promising in Phase I Results

Intravacc announces positive preclinical data for its OMV-based Lyme vaccine

Intravacc announces positive preclinical data for its OMV-based Lyme vaccine

Researchers determine the safety and immunogenicity of a novel candidate vaccine against Lyme borreliosis.

United statesLancet infectious diseasesNorth americaBorrelia ospaOspac terminal